WAYNE B. BATCHELOR, M.D.

Plain English
Researchers looked at a new type of bio-based film made from cellulose and lignin nanoparticles to see how these materials could improve its properties. They found that adding lignin made the film completely block harmful UV light, achieving 100% protection compared to just 20% without it. This film also became less water-attracting; in fact, the water contact angle increased from 58° to 99°. Who this helps: This benefits manufacturers of packaging materials and consumers looking for environmentally-friendly options.

Plain English
This study looked at a new type of silk material called microfibrillated silk (MFS) to see how different processing methods affect its properties for use in medical applications. Researchers found that processing MFS in different ways influenced its strength and how cells responded to it, with papers made using acid treatment and specific mechanical processing providing the best results for cell attachment. These findings are important because they help in creating silk-based materials that can be customized for medical uses, like tissue engineering. Who this helps: This benefits researchers and developers in the biomedical field.

Plain English
This study looked at improving biodegradable films made from cellulose and polylactide to use for food packaging. Researchers found that by soaking the cellulose films in a special solution for 24 hours, they could reduce the amount of moisture that passes through the films to just 5.4 grams per square meter per day, making them almost as effective as traditional plastics like polypropylene, which has a rate of 2.8 grams per square meter per day. This matters because it could lead to more environmentally friendly packaging options for food that needs to stay dry and fresh. Who this helps: This benefits food manufacturers and consumers looking for sustainable packaging solutions.

Plain English
This study looked at how the number of procedures performed by doctors (called "operator volume") affects patient outcomes after two types of heart valve surgeries: transcatheter aortic valve replacement (TAVR) and mitral transcatheter edge-to-edge repair (MTEER). The researchers found that patients operated on by doctors who did fewer procedures (less than 15 for TAVR and less than 8 for MTEER annually) had worse outcomes, with low-volume TAVR surgeons showing a 13% higher risk of death within 30 days and 9% more in-hospital complications compared to high-volume surgeons. These findings are important because they highlight that patients may have better chances for successful outcomes when operated on by experienced surgeons, which can guide healthcare policies on procedure distribution. Who this helps: This helps patients needing heart valve surgery and their families by emphasizing the importance of choosing experienced doctors.

Plain English
This study looked at the early results of two procedures for treating problems with the tricuspid valve in the heart: transcatheter tricuspid valve replacement (TTVR) and edge-to-edge repair (T-TEER). Out of nearly 1,000 procedures performed at 142 different hospitals, 97% of patients who had TTVR and 74% of those who had T-TEER were left with only moderate or less severity of their heart valve issue after 30 days. Importantly, both procedures led to significant improvements in quality of life for many patients, with the estimated death rates within 30 days being about 3.0% to 3.9%. Who this helps: This information benefits patients with tricuspid regurgitation and their doctors by providing insights into effective treatment options.

Plain English
The research focused on improving the safety of a medical imaging technique called fluoroscopy, which helps doctors see inside the body during procedures. The panel, consisting of representatives from 32 medical organizations, identified key issues like inconsistent training and varying safety regulations, and they made a series of recommendations to establish clear and uniform training standards that all healthcare providers should follow. This is important because it aims to protect patients from radiation exposure and ensure healthcare providers are well-trained, leading to safer procedures with better outcomes. Who this helps: This helps patients and healthcare providers by ensuring safer medical imaging practices.

Plain English
This study looked at how to improve the ability to 3D print with hydrogels, which are gel-like materials. The researchers tested different combinations of cellulose-based materials and found a way to predict how well these gels could hold their shape during printing. Their model showed it could accurately determine how far the gel could be stretched without sagging, which is important for creating high-quality printed objects. Who this helps: This helps engineers and researchers developing better 3D printing materials for medical applications.

Plain English
This study looked at whether films made from cellulose nanofibrils (CNF) could work as effective barriers against moisture, aiming to replace common plastics used in packaging. The researchers created over 200 different CNF films with varying thicknesses and found that as the films became thicker, their ability to prevent water vapor from passing through improved; however, they still couldn't match the performance of traditional plastics like polyolefins. Specifically, the water vapor transmission rates decreased significantly, but even at their best, the CNF films couldn't fully block moisture, indicating that extra improvements are needed, such as adding coatings or fillers, to make them viable for packaging. Who this helps: This research benefits packaging manufacturers looking for more sustainable materials.

Plain English
This study examined the outcomes of younger patients (under 65) who received a specific type of heart valve replacement called transcatheter aortic valve replacement (TAVR) and compared them to older patients (ages 65 to 80). The researchers found that younger patients had more health issues and experienced higher rates of hospital readmissions (28.2% vs. 26.1%) and deaths (9.9% vs. 8.2%) within a year after the procedure, although their survival rates were similar when matched for other health factors. This is important because it highlights the need for careful evaluation of younger patients’ health conditions when deciding on TAVR, as they may face more complications than previously thought. Who this helps: This research benefits doctors and healthcare teams involved in managing heart valve disease, particularly for younger patients.

Plain English
This study looked at how a treatment called TriClip affects heart changes in patients with severe tricuspid regurgitation (TR), a heart valve issue. The researchers found that after 30 days, TR volume decreased by 70% in patients who received the TriClip, and there were also significant reductions in the volume of the heart's right ventricle and tricuspid area, with these improvements lasting for a year. The findings are important because they show that TriClip not only reduces the severity of TR but also leads to positive changes in heart shape and function. Who this helps: This helps patients with severe tricuspid regurgitation by offering an effective treatment option.

Plain English
This study looked at new, eco-friendly materials for packaging made from cellulose, which is found in plants. Researchers found that by adding a certain amount of cellulose fibers, called cellulose nanofibrils, to the transparent cellulose films, they became stronger and easier to use, even though they were a bit less clear. The best results came with a 25% addition of these fibers, which kept water vapor out effectively while still allowing good oxygen protection—better than most plastic films made from oil. Who this helps: This benefits manufacturers looking for sustainable packaging solutions.

Plain English
This study focused on improving the way we analyze cellulose nanofibril (CNF) films, which are materials made from plant fibers that have potential commercial uses. The researchers combined two techniques—mercury intrusion porosimetry (MIP) and X-ray micro-computed tomography (µCT)—to better understand the structure of these films. By using MIP first, they were able to fill the tiny pores in the films with mercury, making it easier for µCT to create clear 3D images. This method allowed the team to get detailed information about the pore sizes and shapes, which is crucial for determining how these materials can be used effectively. Who this helps: This research benefits manufacturers and scientists working with new materials, particularly in the field of sustainable packaging and other applications of cellulose-based materials.

Plain English
Researchers studied a treatment called transcatheter edge-to-edge repair (TEER) for patients with severe tricuspid regurgitation, a heart condition that can lead to serious symptoms. After two years, they found that patients who received the TEER treatment had significantly fewer hospitalizations for heart failure (0.19 vs. 0.26 events per patient-year) and a much higher rate of being free from death and the need for additional surgeries (77.6% for TEER vs. 29.3% for standard treatment). This is important because it shows that TEER not only improves symptoms but also helps patients live longer and avoid more invasive procedures. Who this helps: This benefits patients with severe tricuspid regurgitation.

Plain English
This study looked at how effective a special balloon coated with a drug called paclitaxel is for treating patients with a condition called multilayer in-stent restenosis (ISR), which happens when scar tissue forms in multiple layers of stents. Out of 600 patients, those with multilayer ISR had a 29% chance of complications after one year, compared to 15.7% for those with only a single layer. For patients with multilayer ISR, the drug-coated balloon resulted in fewer complications—23.8% experienced issues compared to 40% with a regular balloon, which is a significant improvement. Who this helps: This research benefits patients with multiple layers of stents who may face higher risks of complications.

Plain English
This study explored the impact of multiple chronic conditions on patients undergoing a special heart procedure called transcatheter aortic valve intervention (TAVI). Among the nearly 189,000 patients, those with six or more chronic conditions were found to have a significantly higher risk of dying within a year (about 2.3 times more likely) compared to those with fewer than four conditions. However, most patients with multiple chronic issues still showed significant improvements in their quality of life after the procedure, regardless of their health challenges. Who this helps: This research benefits patients with aortic stenosis and their doctors by providing insights into expected outcomes and quality of life improvements after TAVI.

Plain English
This review focused on the use of blood-thinning medications (antithrombotic therapies) for patients undergoing heart-related procedures. It highlighted the need for careful management of these medications to reduce the risk of serious bleeding, especially in older patients who are more vulnerable. The review aims to clarify guidelines and provide a straightforward summary of best practices for doctors, ensuring that patients receive safer and more effective treatment during their procedures. Who this helps: This helps patients undergoing heart procedures and the doctors who treat them.

Plain English
This study looks at ways to simplify how we measure the properties of cellulose suspensions, which are important for their use in industries. Researchers created a dataset that helps estimate key characteristics, such as aspect ratio, using just one sedimentation test instead of many, achieving errors of less than 7% for gel point calculations and about 3% for aspect ratio estimates. This improvement matters because it makes the production of these materials more efficient, saving time and resources. Who this helps: This helps manufacturers and researchers working with cellulose-based materials.

Plain English
Researchers compared a special balloon coated with a drug called paclitaxel to a standard uncoated balloon in 600 patients experiencing a problem known as in-stent restenosis, where blood vessels narrow again after treatment. They found that after one year, only 17.9% of patients who received the paclitaxel-coated balloon faced complications, compared to 28.6% of those who got the uncoated balloon, showing that the drug-coated option is better at preventing issues. This matters because it provides a more effective treatment choice for patients with this condition, potentially leading to fewer heart-related problems. Who this helps: This helps patients with coronary in-stent restenosis.

Plain English
This study examined how well patients in a major heart failure medical trial represented the larger population of heart failure patients using Medicare data. They found that although the trial included a good number of African Americans and adequately captured demographics for certain groups, women were underrepresented, making up only 27% of the trial participants. This matters because a lack of diversity in trials can lead to health treatments that don’t effectively address the needs of all patients, potentially widening health disparities. Who this helps: This helps patients with heart failure, especially women and minority groups.

Plain English
This research paper studied the issue of damage to the heart that occurs after restoring blood flow in patients who have had a heart attack. It found that this "reperfusion injury," caused by factors like inflammation and oxidative stress, can lead to additional heart tissue damage. Improving the management of this injury is essential, as patients still face high mortality rates after heart attacks, even with better treatments. Who this helps: Patients who have experienced heart attacks and healthcare providers treating them.

Plain English
This study focused on cardiogenic shock, a serious condition where the heart can't pump enough blood, affecting about one in three patients who develop it. The American Heart Association has created a registry that collects detailed information from hospitals across the U.S. to better understand how this condition is treated and the outcomes for patients. So far, 100 hospitals are involved, which will help improve care and save lives by providing data for research and improving treatment methods. Who this helps: This benefits patients with heart conditions, doctors, and healthcare providers.

Plain English
This study looked at how genetic differences affect the effectiveness of oral medications (P2Y12 inhibitors) that prevent blood clots in patients with heart conditions and strokes. Researchers found that patients with certain genetic variants are less likely to benefit from the commonly used drug clopidogrel, leading to more heart-related issues, while those without these variants do better on it. By using genetic testing, doctors can prescribe the right medication for each patient, potentially reducing the risk of heart problems without increasing the chance of bleeding. Who this helps: This helps patients with acute coronary syndromes and doctors treating them.

Plain English
This study looked at the effects of three different compounds—25-hydroxycholesterol, lipoic acid, and obeticholic acid—on the flexibility of mouse lenses, which can help in understanding treatments for age-related vision problems like presbyopia. Researchers found that older mouse lenses were stiffer and less flexible than younger ones, with 25-hydroxycholesterol showing a significant effect in making them more pliable, while lipoic acid did not produce the expected results. This research matters because it could lead to better treatments for age-related vision issues in humans. Who this helps: This helps patients experiencing age-related vision problems.

Plain English
This study focused on how to treat young and low-risk patients with aortic stenosis, a heart condition. The research showed that both transcatheter aortic valve replacement and surgical aortic valve replacement have strong success rates, with excellent outcomes for patients aged 65 to 80. However, there is growing interest in treating patients younger than 65, and the study produced guidance for doctors to help them decide the best treatment for this age group. Who this helps: This benefits young patients with aortic stenosis and the doctors treating them.

Plain English
This study looked at how cellulose nanocrystals (CNC), which are tiny rod-like structures made from plant material, organize themselves in water based on their length. Researchers found that shorter CNC rods can align into an ordered arrangement at certain concentrations, while longer rods remain disorganized regardless of concentration. This understanding is important because it can help in creating new materials with special properties for uses in sensors and medical diagnostics. Who this helps: This benefits researchers and companies developing advanced materials for technology and healthcare.

Plain English
This study looked at how applying fats found in eye fluid affects the stiffness of a part of the eye called the trabecular meshwork, which is important in managing eye pressure. Researchers found that treating trabecular meshwork samples with lipids changes their stiffness, which could be beneficial for slowing the progression of glaucoma. This matters because controlling eye pressure is crucial for preventing vision loss in glaucoma patients. Who this helps: This helps patients with glaucoma.

Plain English
This study looked at the mechanical properties of the meniscus, a crucial tissue in the knee, using a technique called Atomic Force Microscopy. Researchers found that the ability of the meniscus to compress under load varied significantly depending on the direction tested; it was stronger in the circumferential direction than in the axial direction, with an average compressive strength of about 2.04 MPa. Understanding these properties is important because it helps explain how the meniscus works and could lead to better treatments for knee injuries and conditions like osteoarthritis. Who this helps: This benefits patients with knee injuries and doctors treating those conditions.

Plain English
This study examined the outcomes of a specific type of heart procedure called percutaneous coronary intervention (PCI) in patients who had previously undergone coronary artery bypass graft (CABG) surgery. It looked at 4,175 patients, including 1,858 women and 1,057 minorities, and found that those with a history of CABG had a higher risk of major heart problems—12.6% compared to 7.5% in patients without prior CABG. However, after adjusting for various health factors, the additional risk linked to having had CABG was not significant, indicating that factors other than previous surgery play a bigger role in outcomes. Who this helps: This information benefits doctors and cardiac patients, particularly those who are considering PCI after CABG surgery.

Plain English
This study looked at how different types of salts (electrolytes) affect the arrangement of tiny cellulose crystals in a liquid. Researchers found that adding electrolytes changes the structure of the crystals—starting with a weaker structure and eventually causing them to clump together at higher salt concentrations. Specifically, single-charged electrolytes had a greater impact, breaking down the structure at lower levels than those with two charges. This research is important because it helps improve the design of new materials for things like sensors and optical devices that use these cellulose crystals. Who this helps: This helps developers of advanced materials and optical technologies.

Plain English
This study focused on how to improve heart procedures for older adults by using a special team that includes experts in aging. It found that adding geriatric specialists to the usual heart care team can help doctors better assess risks before procedures and make more informed decisions that consider the unique needs of older patients. This is important because it can lead to better health outcomes and make sure that the care matches what older patients value most. Who this helps: This helps older patients undergoing heart procedures and their doctors.

Plain English
This study looked at how to better assess and manage older adults undergoing heart procedures, specifically percutaneous coronary interventions (PCI). The experts found that using standard risk assessment tools is important, but they recommend adding a new way to evaluate risks related to aging, called geriatric syndromes. This addition could help identify older patients who might face higher risks of complications from these procedures. Who this helps: This benefits older patients undergoing heart procedures and their healthcare providers.

Plain English
This study looked at the MitraClip device used to treat patients with secondary mitral regurgitation (a condition where blood leaks backward into the heart). Over 5,000 patients were treated, and the results showed that 90.7% of patients had a significant reduction in their heart condition after one year, and hospitalizations for heart failure decreased to 18.9%. These findings are important because they demonstrate that the MitraClip is safe and effective for a wider range of patients than previously studied. Who this helps: This helps patients with secondary mitral regurgitation and their doctors.

Plain English
This study looked at how race, ethnicity, and sex affect the health outcomes of diabetic patients after they receive coronary artery stents. Researchers found that diabetic minority women experienced significantly more serious heart issues within a year after the procedure—14.4% had major complications compared to just 7.5% of patients without diabetes. This difference highlights that diabetic minority women are at a higher risk and need closer monitoring and better diabetes management after getting stents. Who this helps: This research benefits diabetic minority women and their healthcare providers by emphasizing the need for targeted care.

Plain English
This study looked at 520 patients with cardiogenic shock, a serious heart condition, to see if there were differences between men and women in their health outcomes while receiving standardized treatment. The results showed that women appeared to have more severe initial conditions but had similar chances of survival in the hospital to men, with 45.2% of women and 36.9% of men dying while hospitalized for acute myocardial infarction, and 28.1% of women and 24.5% of men for heart failure. However, women were more likely to face severe bleeding and vascular complications than men, with rates of 25.8% and 15.7% respectively compared to men’s 13.7% and 6.1%. Who this helps: This research aids doctors and healthcare teams in understanding how to better support both men and women with cardiogenic shock.

Plain English
The SMART Trial is studying two leading heart valve replacement devices in patients with a specific heart condition called aortic stenosis, particularly those with smaller aortic valves, which often includes more women. The trial includes around 700 patients across 90 locations worldwide and focuses on key outcomes like survival, stroke, and rehospitalizations after one year, as well as how well the valves function during that time. This research is significant because it addresses an underrepresented group in heart studies and aims to provide clear comparisons on the best treatment options for these patients. Who this helps: This helps patients with small aortic valves and their doctors by providing important data on effective treatment options.

Plain English
This study looked at the use of two types of heart valve procedures—transcatheter edge-to-edge repair (TEER) and transcatheter mitral valve replacement (TMVR)—in the U.S. from 2014 to March 2020. It found that the number of these procedures significantly increased, with TEER procedures rising from 1,152 in 2014 to 10,460 in 2019, and the 30-day mortality rate for TEER patients dropped from 5.6% to 4.1%. This is important because it shows that more patients are receiving these treatments and that they are doing better than before. Who this helps: This helps patients with heart valve issues and their doctors by providing better treatment options and outcomes.

Plain English
This study looked at older adults aged 75 and over who were hospitalized for a heart attack and how having heart failure (HF) affected their health and hospital costs. Out of nearly 469,000 patients, about 42,946 (or 9%) had heart failure, which increased their risk of death to 12% and resulted in longer hospital stays (an average of 5 days) compared to those without heart failure. The presence of heart failure not only raised healthcare costs by an average of $1,075 but also meant that a higher percentage of these patients were sent to rehabilitation or hospice care, making it important to identify heart failure early in these patients for better care. Who this helps: This benefits elderly patients with heart conditions and healthcare providers managing their care.

Plain English
This study looked at how to help older adults with heart disease who are also physically frail. Researchers found that while no single intervention has been proven to significantly reduce overall frailty, some patients with heart failure benefit from a combination of supports like personalized rehabilitation programs. This is important because addressing frailty can improve physical function and overall quality of life after heart treatments. Who this helps: This helps older patients with heart disease and their healthcare providers.

Plain English
This study looked at how to process cellulose using iron oxide catalysts and hydrogen peroxide to create two types of materials: nanocellulose fibers and water-soluble oxidized cellulose. The research found that by adjusting certain factors, they could produce nanocellulose with a high yield of 83% and water-soluble cellulose with a yield of 38%. This new method is important because it avoids harmful chemicals and makes the production of these useful materials more efficient and eco-friendly. Who this helps: This helps manufacturers of biodegradable materials and researchers working on sustainable products.

Plain English
Researchers developed a simple tool to quickly detect harmful bacteria in water, which is important for preventing waterborne illnesses. This new biosensor can identify both types of bacteria—Gram-positive and Gram-negative—at very low concentrations, as low as 10 cells per milliliter. It works by changing color when bacteria are present, making it easy to use without special equipment. Who this helps: This helps patients and communities by ensuring safer drinking water.

Plain English
This study looked at how transcatheter aortic valve replacement (TAVR) is used and what the outcomes are based on race, ethnicity, and sex from 2013 to 2017. It found that while TAVR usage increased overall, minority groups and women experienced slower growth, with Hispanic and White females facing the highest in-hospital death rates between 2.7% and 3.3%. Moreover, women of all races had more complications than men, despite having fewer pre-existing health issues. Who this helps: This research benefits patients, especially women and those from minority backgrounds, by highlighting disparities in heart valve replacement care.

Plain English
This study looked at how to make a new type of packaging material called nanopaper, which is created from cellulose fibers, to see if it could replace traditional plastic packaging. The researchers found that after roughly 1800 to 12,000 kilowatt-hours of refining energy, the nanopaper reached a point where its ability to block oxygen and water was significantly better than existing plastics, with oxygen permeability around 1.24 and water vapor permeability at about 3×10 g/m·s·Pa. This matters because nanopaper has the potential to be a more sustainable option for packaging that is both strong and environmentally friendly. Who this helps: This helps manufacturers looking for eco-friendly packaging solutions.

Plain English
This study looked at using cellulose nanofibril (CNF) films as an eco-friendly alternative to plastic packaging. Researchers found that CNF films can be produced efficiently through a technique called spray deposition, which offers good strength and oxygen protection, although moisture protection is still limited. This is important because creating sustainable packaging options can help reduce environmental pollution caused by traditional plastics. Who this helps: This benefits manufacturers looking for sustainable packaging solutions.

Plain English
This study looked at how physical frailty affects heart health and overall survival in older adults who don't have a history of heart disease. Researchers found that frail participants, who were mostly older and included more women and ethnic minorities, faced significantly higher risks: they were 2.7 times more likely to die and 1.77 times more likely to experience major heart problems compared to those who were not frail. This matters because recognizing and addressing frailty in these patients could help prevent serious heart issues and improve their overall health. Who this helps: This helps older adults, particularly those with frailty, as well as their doctors who manage their care.

Plain English
This study looked at nearly 37,500 patients in the U.S. who underwent treatments for mitral valve problems using two procedures: transcatheter edge-to-edge repair (TEER) and transcatheter mitral valve replacement (TMVR) from 2014 to March 2020. Researchers found that the number of TEER procedures rose significantly from 1,152 in 2014 to 10,460 in 2019, while the 30-day death rate for TEER dropped from 5.6% to 4.1%. These findings show that more patients are receiving these treatments, and outcomes are improving, which is important for better patient care and recovery. Who this helps: This helps patients with mitral valve issues and their doctors.

Plain English
The study looked at a rare condition where a blood vessel called the left main coronary artery connects directly to another vessel, the superior vena cava. This unusual connection was found in a patient while they were being treated for an unrelated serious infection. Understanding and identifying this condition is important because it can affect how blood flows in the body and may require a team of specialists to manage it effectively. Who this helps: This helps patients with rare heart conditions and the doctors treating them.